| Literature DB >> 31861471 |
Gerardo Grasso1, Daniela Zane1, Roberto Dragone1.
Abstract
Nanomaterials are increasingly being used in new products and devices with a great impact on different fields from sensoristics to biomedicine. Biosynthesis of nanomaterials by microorganisms is recently attracting interest as a new, exciting approach towards the development of 'greener' nanomanufacturing compared to traditional chemical and physical approaches. This review provides an insight about microbial biosynthesis of nanomaterials by bacteria, yeast, molds, and microalgae for the manufacturing of sensoristic devices and therapeutic/diagnostic applications. The last ten-year literature was selected, focusing on scientific works where aspects like biosynthesis features, characterization, and applications have been described. The knowledge, challenges, and potentiality of microbial-mediated biosynthesis was also described. Bacteria and microalgae are the main microorganism used for nanobiosynthesis, principally for biomedical applications. Some bacteria and microalgae have showed the ability to synthetize unique nanostructures: bacterial nanocellulose, exopolysaccharides, bacterial nanowires, and biomineralized nanoscale materials (magnetosomes, frustules, and coccoliths). Yeasts and molds are characterized by extracellular synthesis, advantageous for possible reuse of cell cultures and reduced purification processes of nanomaterials. The intrinsic variability of the microbiological systems requires a greater protocols standardization to obtain nanomaterials with increasingly uniform and reproducible chemical-physical characteristics. A deeper knowledge about biosynthetic pathways and the opportunities from genetic engineering are stimulating the research towards a breakthrough development of microbial-based nanosynthesis for the future scaling-up and possible industrial exploitation of these promising 'nanofactories'.Entities:
Keywords: applied microbiology; diatom nanotechnology; drug delivery; green chemistry; nanostructured materials; sensoristic devices; theranostics; white biotechnology
Year: 2019 PMID: 31861471 PMCID: PMC7023511 DOI: 10.3390/nano10010011
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Schematic comparing average sizes of the microorganisms described in this review.
Nanomaterials synthesized by bacteria.
| Microorganism | Culture Conditions (Synthesis Time) | Nanomaterial | Characterization | Biosynthetic Pathway | Application | Ref. |
|---|---|---|---|---|---|---|
|
| Enrichment medium, 35 °C, stirred at 170 rpm + 4 mM Na2SeO3 (48 h) | Se NPs | 50–400 nm; spherical regular morphology; 100 nm uniform single-crystalline; nanowires | Reduction mechanism of SeO32− ions to Se0 is yet to be elucidated | H2O2 sensoristic device | [ |
| 5 g of wet bacterial biomass from 120 h cell culture + 1 mM Na2SeO3, stirred at 200 rpm (72 h) | Se NPs | 10–250 nm; spherical shape; crystalline; | Extracellular synthesis not described | Anti-biofilm, antioxidant activity, antiviral activity against Dengue virus; anti-proliferative activity against HeLa and HepG2 cell lines | [ | |
| 1% ( | Se NPs | <100 nm; spherical shape; amorphous form size vary with culture time (10–24 h); | Intracellular reduction of Se (IV) to Se (0) and subsequent excretion | High antioxidant activity (when stabilized with L-cysteine) | [ | |
| 1 mL fresh bacteria inoculums (OD600 = 0.5 a.u.) in international | Se NPs | 600 nm length, 17 nm diameter | Possible involvement of proteins/enzymes in SeO2 reduction nucleation, growth, stabilization of nanorods | In vitro anticancer activity against human breast adenocarcinoma cell line and human liver carcinoma cell line | [ | |
| 10 h culture, resuspended in sterile distilled water + 1 mM HAuCl4, room temperature (120 h) | Au NPs | 25 ± 8 nm; spherical shape; crystalline form (face centered cubic phase) | Extracellular synthesis possibly modulated by sugars or enzymes present onto bacteria surface | Direct electro-chemistry of hemoglobin | [ | |
| Washed cell pellet from a 24 h cell culture + 1 mM HAuCl4, 30 °C, stirred at 200 rpm (48 h) | Au NPs | 12 ± 5 nm; spherical shape, | Extracellular synthesis possible electron shuttle-based enzymatic reduction of ionic Au3+ to Au0 | No antibacterial properties/annealing and thin film formation | [ | |
| Cell-free supernatant (from a 96 h cell culture) + 0.9 mM HAuCl4, incubated in the dark, 35 °C, stirred at 180 rpm (48 h) | Au NPs | 11.57 ± 1.24 nm; spherical shape; face centered cubic; | Extracellular synthesis using the cell free supernatant, proteins, enzymes and metabolites | High antimicrobial activity against | [ | |
|
| 1 g of wet bacterial biomass + 1 × 10−3 M AgNO3 + 1 × 10−3 M HAuCl4, 37 °C, stirred at 200 rpm (24 h) | Au and Ag NPs | Ag 10–50 nm, Au, 0–50 nm; spherical shape, crystalline form (face centered cubic phase) | Intracellular synthesis, possible roles of NADH-dependent nitrate reductase (for Ag NPs) and α-NADPH-dependent sulfite reductase (for Au NPs) | Anti-coagulant properties | [ |
| ∼3–5 g of wet bacterial biomass from 24 h cell culture + 1 mM AgNO3, 30 °C stirred at 200 rpm (48 h | Ag NPs | ∼2–11 nm spherical shape; crystalline form; | Extracellular synthesis by secreted factors (e.g., NADH-dependent reductases, quinines, soluble electron-shuttles) | Antibacterial activity against | [ | |
| 100 mg of fresh weight biomass + 9 mM Ag(I) solution (pH 4) incubated in the dark, room temperature (72 h) | Ag NPs | ∼5–50 nm; spherical shape, crystalline form (face-centered cubic), smooth surface morphology, both (sonication) | Extracellular and intracellular synthesis not described | Effective antibacterial activity against | [ | |
| Broth-free cell pellets (14-days cell culture) in sterile distilled water for 1 h; cell removed from the suspension + 1–5 mM AgNO3, 37 °C (48 h) | Ag NPs | 20–50 nm; spherical shape | Extracellular synthesis possibly via hydrophilic and hydrophobic small metabolites attached on the bacteria cell wall | In vitro antimicrobial activity against | [ | |
|
| 2 g of wet bacterial biomass + 1 mM AgNO3, 37 °C, stirred at 200 rpm (24 h) | Ag NPs | 40 nm to 50 nm | N/A | Possible application as anti-proliferative and anti-migration agent e.g., against diabetic retinopathy, neoplasia and rheumatoid arthritis | [ |
| Bacterial culture (OD600 = 0.6 a.u.), Luria Bertani medium + 3 mM CdCl2 + 6 mM Na3C6H5O7 + 0.8 mM Na2TeO3, 8 mM C4H6O4S + 26 mM NaBH4, 37 °C, stirred at 200 rpm (24 h) | CdTe QDs | ∼2–3 nm; uniform size, cubic crystals; strong fluorescence emission shift with increasing quantum dots size, capping proteins were not identified but enhance QDs biocompatibility; | Extracellular synthesis possibly via protein-assisted nucleation biosynthesis | Possible application in vitro cell imaging (demonstrated on HeLa cells) and bio-labeling | [ | |
|
| Static culture in polysaccharides enriched medium, 30 °C (120 h) | Bacterial nanocellulose nanofibrils | Nanoporous three-dimensional network structure with a random arrangement of ribbon-shaped microfibrils without any preferential orientation; | Intracellular-extracellular synthesis via enzymes glucokinase, phosphoglucomutase, UDPG, pyro-phospho-rylase and cellulose synthase | In vitro pH-responsive antimicrobial activity against | [ |
|
| N/A | Ag NPs and bacterial nano-paper composite | AgNPs 10–50 nm | Intracellular-extracellular synthesis of bacterial nanocellulose via enzymes glucokinase, phosphoglucomutase, UDPG, pyro-phospho-rylase and cellulose synthase | Optical detection of cyanide ion and 2-mercaptobenzo-thiazole in water samples | [ |
|
| Static culture containing 50 g/L glucose, 5 g/L yeast extract, 5 g/L (NH4)2SO4, 4 g/L KH2PO4 and 0.1 g/L MgSO4·7H2O, 28 °C (366 h) | Nanocompositesof bacterial nanocellulose with AgNP, Au-NPs CdSe@ZnS quantum dots functionalized with biotinylated antibodies, aminosilica-coated lanthanide-doped up-conversion NPs | (bacterial nanocellulose) 45 ± 10 nm (fiber mean diameter); estimated length > 10 μm | Intracellular-extracellular synthesis via enzymes glucokinase, phosphoglucomutase, UDPG, pyro-phospho-rylase and cellulose synthase | Optical detection of methimazole, thiourea, cyanide, and iodide and | [ |
| 200 mg biomass + 2.4 × 10−5 M graphene oxide dispersion mixture, 37 °C (72 h) | Reduced graphene oxide nanosheets | ~4.3 nm (average thickness), significant reduction of GO (assessed by XRD analysis); several layers stacked on top of one another like silky sheets of paper (SEM image) | Extracellular synthesis not described | Inhibition of cell viability, reactive oxygen species (ROS) generation, and membrane integrity alteration in MCF-7 cell line | [ | |
| Anaerobically grown in 5 ml/L of Wolfe’s mineral solution (without iron), + 5 mM KH2PO4 + 10 mM NaNO3 + 0.85 mM C2H3NaO2 + 0.2 mM C6H8O6 + 2.5 mM C4H6O6 + 0.6 mM Na2S2O3, pH 6.9; cell pellets were resuspended in 20 mM HEPES + 1 mM EDTA + 8% glycerol + 0.9% NaCl, pH 7.5 | Magnetosome | Magnetosome membrane modified with Venus-RGD protein as specific and sensitive molecular imaging probe | Natural mechanism of magneto-somes formation (biomineralization) | Contrast agent for in vivo magnetic resonance-based molecular imaging | [ | |
| Micro-anaerobically grown in a similar culture medium of [ | Whole inactive magnetotactic bacteria | Magnetosomes chains (length) ∼150 or ∼300 nm; individual magnetosomes mean size ∼45 nm; well-crystallized monodomain with a ferromagnetic behavior at physiological temperature | Natural mechanism of magneto-somes formation + genetic modification for Venus protein- RGD peptide expression | Antitumoral activity against MDA-MB-231 breast cancer cells under alternating magnetic field stimulation | [ | |
| Micro-anaerobically grown in a similar culture medium of [ | Chains of magnetosomes | Magnetosome membrane modified with Red-emitting Click Beetle luciferase (CBR) | Natural mechanism of magneto-somes formation + genetic modification for red-emitting click beetle luciferase expression | Toxicity assay on microfluidic chip for the detection of toxicity effect on membrane by DMSO and TCDCA | [ |
Nanomaterials synthesized by yeasts and molds.
| Microorganism | Culture Conditions (Synthesis Time) | Nanomaterial | Characteristics (Average Size, Morphology, etc.) | Biosynthetic Pathway | Application | Ref. |
|---|---|---|---|---|---|---|
|
| Aerobic two days growth in a modified Czapek’s medium, 5 °C; aliquot of cell suspension (OD600 = 0.6) + 3 mM CdCl2 + 0.8 mM Na2TeO3 + 1.5 mM CH3SO3H + 2.6 mM NaBH4, stirred at 500 rpm (N/A) | CdTe QDs | 2.0–3.6 nm; cubic zinc blende crystals | Extracellular synthesis not described | Good candidate for bio-imaging and bio-labelling applications | [ |
| Growth in Czapek’s medium; pH 7.3 ± 0.2, 30 °C for 7 days shaken at 150 rpm + 2 mmol K2TeO3 (48 h) | Te NPs | 60.80 nm; oval to spherical shape | Mechanism not described | Antibacterial activity against | [ | |
| Commercially available instant dry yeast (Angel Yeast Co.—Yichang, China) | Sucrose solution (5 g/L) + instant dry yeast (600 mg), 30 °C for 24 h; cells pellet in sterile water (106 cells/mL) + AgNO3 solution + HAuCl4 solution (final concentrations N/A), 30 °C. (24 h) | Au–Ag alloy NPs | Reduced metallic form (XPS analysis); | Extracellular synthesis not described | Electrochemical sensor for paracetamol | [ |
| Au–Ag alloy NPs | 9–25 nm | Extracellular synthesis not described | Electrochemical sensor for vanillin | [ | ||
| MGYP medium, pH 9, shaken at 200 rpm, 50 °C; harvested mycelial mass + 1 mM AgNO3, shaken at 200 rpm, 50 °C (96 h) | Ag NPs | 5–25 nm; spherical shape; face centered cubic crystals | Extracellular synthesis through a possible involvement of biomolecules secreted by the fungus | In vitro cytotoxicity against NIH3T3 mouse embryonic fibroblast cell line and MDA-MB-231 human breast carcinoma cell line | [ | |
| 5 days growth, potato dextrose broth, 28 °C; filtered biomass + 1 mM AgNO3, 28 °C, dark condition (120 h) | Ag NPs | 5 to 13 nm; spherical shape; face centered cubic crystals | Extracellular synthesis, possible involvement of a secreted reductase | Antibacterial activity against pathogenic bacteria | [ | |
| 72 h growth, potato dextrose broth, 30 °C, shaken at 200 rpm; filtered biomass (5 g) in Milli-Q sterile deionized water and agitated, 72 h at 200 rpm, 30 °C; supernatant from filtered biomass + 1 mM HAuCl4, shaken at 200 rpm, dark condition 30 °C (N/A) | Au NPs | (live cell filtrate) 25–60 nm; spherical shape; 20–80 nm (potato dextrose broth), spherical and triangular and hexagonal shape | Extracellular synthesis; possible ion trapping on the fungal cells surface via electrostatic interaction; possible involvement of organic reagents used for the microbial cultivations as potential reducing agents | Inhibitory effect and cytotoxicity against mouse cancer C2C12 cell lines | [ | |
| 72 h cultured spores in wheat bran broth media, 28 °C shaken at 180 rpm; supernatant + 0.5% ( | Chitosan NPs | 90.8 nm; spherical shape; amorphous structure | Extracellular synthesis via enzyme secreted (not identified) | Antioxidant activity; bactericidal activity against | [ | |
|
| Growth in potato dextrose broth, 28 °C, 115 rpm; harvested fungal biomass + 3 mM ZnSO4, 27 °C, 200 rpm; for ZnS:Gd nanoparticle 0.3 M Gd(NO3)3 (96 h) | ZnS and ZnS: Gd NPs | Nanocrystalline and a narrow size distribution: 12–24 nm spherical (ZnS): for and 10–18 nm (ZnS:Gd) | Extracellular synthesis not described | Optical detection of Pb (II), Cd (II), Hg (II), Cu (II), and Ni (II) in water | [ |
|
| Growth in potato dextrose broth + 0.5 mM Pb(CH3COO)2 + 6.4 mM Na2S, 30 °C, 115 rpm (120 h) | PbS NPs | 35–100 nm; cubic crystal | Extracellular synthesis not described | Optical detection of As (III) in water | [ |
Nanomaterials synthesized by microalgae.
| Microorganism | Culture Conditions (Synthesis Time) | Nanomaterial | Characteristics (Average Size, Morphology, Modification) | Biosynthetic Pathway | Application | Ref. |
|---|---|---|---|---|---|---|
|
| Guillard’s Marine Enrichment medium at 28 °C, 200 rpm, 15 days, light condition. 10 g of washed harvested cells + 1 mM HAuCl4, 200 rpm, 28–29 °C (48 h) | Au NPs | 5–35 nm; spherical and triangular shape | Intracellular synthesis; possible reduction via enzymes present in the cell wall and in the cytoplasmic membrane | Various applications including catalysis, electronics and coatings | [ |
| Growth in Modified Bold Basal medium, 28 ± 2 °C, 16:8 h light: dark cycle,126 rpm; washed pelleted biomass (harvested in the logarithmic growth phase) + 5 mM AgNO3, 28 °C in the same growth conditions (72 h) | Ag NPs | (living cells) 3–35 nm; spherical shape, highly crystalline cluster; | Intracellular synthesis not described. | Good antimicrobial activity against | [ | |
| Growth in BG-11 medium for 15–20 days, 12:12 h light: dark cycle, 28 ± 2 °C, 120 rpm; centrifuged harvested biomass + 5 mM AgNO3, 28 °C in the same growth condition (72 h) | Ag NPs | (whole cells); 10–30 nm; ζ-potential = −20.2 mV; | Intracellular synthesis not described | Antibacterial effect against | [ | |
|
| One-week growth (cell density 106 cells mL−1) in silicate-enriched seawater media, 18–20 °C, 12:12 h light: dark cycle | Biogenic silica (frustules) modified with murine monoclonal antibody UN1 | Green photoluminescence (peaked between 520 and 560 nm) of silanized frustules | Natural silicification process (bio-mineralization) | Using the biogenic silica photo-luminescence for immunosensors development | [ |
| Growth in Harrison’s Artificial Seawater Medium enriched with f/2 nutrients + 0.7 mM Na2SiO3, 22 °C 14:10 h light: dark cycle. The cell suspension was subcultured at 10% | Biogenic silica (frustules) functionalized with IgG | ~200-nm (perimetrical pores) ~100-nm (linear arrays of pores from the center to the rim) at the base of each ~100-nm pore, a thin layer of silica containing four to five nanopores of ~20-nm diameter | Natural silicification process (bio-mineralization) | Label-free photoluminescence-based immunosensor | [ | |
|
| Growth in F/2 seawater medium, 20 °C, continuous photoperiod | Functionalized biogenic silica (frustules) | 100–200 μm | Natural silicification process (bio-mineralization) | Electrochemical immunosensor for the detection of C-reactive protein and myelo-peroxidase in buffer and human serum samples | [ |
| Growth in F/2 medium, 20 °C, 12:12 h light: dark cycle. The culture media volume was doubled every week to keep high the diatom reproduction rate | Multi-layered package array of biogenic silica (frustules) functionalized with purified primary rabbit IgG | Natural silicification process (bio-mineralization) | Optical immunochip for fluorophore-labeled donkey anti-rabbit IgG detection | [ | ||
|
| Growth in F/2 medium + silica 7 mg mL−1, under aeration 12:12 h light: dark cycle | Biogenic silica (frustules) integrated with Au NPs functionalized with 5,5′-dithiobis (2-nitrobenzoic acid) + anti-interleukin-8 antibodies | 4–5 μm; 98% silica | Natural silicification process (bio-mineralization) | Surface-enhanced Raman scattering immunosensor for the detection of interleukin 8 in blood plasma | [ |
| Growth in Harrison’s artificial seawater medium + 0.5 mM Na2SiO3, 22 °C, 14:10 h light: dark cycle for 21 days. (336 h) | Biogenic silica (frustules) functionalized with anti- 2,4,6-TNT single chain variable fragment derived from the monoclonal antibody 2G5B5 | Ellipsoidal shape with major axe ~20 μm minor axe ~6 μm; pores in rectangular array (~200 nm diameter) spaced 300–400 nm apart. 4–5 nanopores (~50 nm diameter) at the base of each pore | Natural silicification process (bio-mineralization) | Label-free photo-luminescence quenching -based sensor for 2,4,6-trinitro-toluene detection | [ | |
| N/A | Biogenic silica (frustules) coated with gold (multiple layers of Au particles) | 5–10 μm cylindrical-shaped frustules | Natural silicification process (bio-mineralization) | Functional support for surface-enhanced Raman scattering sensor | [ | |
|
| N/A | biogenic silica (frustules) tailored with Au NPs | ~20 nm cylindrical-shaped frustules | Natural silicification process (bio-mineralization) | Detection of bovine serum albumin and mineral oil by surface-enhanced Raman spectroscopy | [ |
|
| Same conditions reported in [ | Biogenic silica (frustules) loaded with streptomycin | Homogeneous size distribution with a radius of 220 ± 15 µm | Natural silicification process (biomineralization | Drug delivery | [ |
| Growth in silicate-enriched seawater media, 18–20 °C, 12:12 h light: dark cycle, final cell density 106 cells mL−1 (168 h) | Biogenic silica (frustules) | Mainly composed of separated valves, porosity and hierarchically ordered nanostructure; luminescent and nanostructured silica shells, combining the dye photoluminescence with the photonic silica nanostructure | Natural silicification process (bio-mineralization) | Loading and delivery of fluoro-quinolone ciprofloxacin | [ | |
| Fossil diatoms | N/A | Biogenic silica (frustules) integrated with 50–60 nm gold nanoparticles | ~400 μm (width of the diatomite channels porous); disk-shaped; extremely high confinement of the analyte and increase the concentration of target molecules at the sensor surface; photonic crystals (substrate for surface-enhanced Raman scattering) with 50–60 nm Au NPs | N/A | On-chip chromatography-surface-enhanced Raman scattering -based microfluidic label-free device for cocaine detection in biological samples | [ |
| Fossil diatoms | N/A | Biogenic silica (frustules) integrated with 50–60 nm Au nanoparticles | 10 to 30 μm; dish-shaped with two-dimensional periodic pores; thickness of the diatomite layer on the glass ~20 μm, (one-third of that of a commercial Thin Layer Chromatography, chip) photonic crystals (substrate for surface-enhanced Raman scattering | N/A | On-chip chromatography-surface-enhanced Raman scattering -based microfluidic label-free device for histamine in salmon and tuna | [ |
| Growth in F/2 medium made with filter sterile brackish water (salinity 3%, pH 8.2), 30 °C, 16:8 h light: dark cycle, 130 rpm; Aqueous cell extract + 2 mM AgNO3, 35–40 °C (30 h) | polycrystalline Ag NPs | 20–25 nm | Extracellular synthesis; photosynthetic pigment fucoxanthin acts as a reducing agent | Antimicrobial activity against | [ | |
| Growth in Artificial seawater (ASW) + f/2 nutrients (without added Si), 20 °C, 12:12 h light: dark cycle, 130 rpm. Cells were harvested at late exponential phase | Aptamer-modified coccolith electrodeposited on the screen-printed Au electrode | N/A | Natural calcification process (coccolitho-genesis) | Aptamer-based sandwich-type electrochemical biosensor for Vaspin (type 2 diabetes biomarker) | [ |